We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: RELEASE OF CRITICAL PATH PRIORITIES LIST PUSHED BACK
FDA: RELEASE OF CRITICAL PATH PRIORITIES LIST PUSHED BACK
December 8, 2004
The FDA’s much-touted Critical Path Initiative to expedite the drug development process has been delayed as other issues, including safety concerns about marketed drugs, have drawn the agency’s attention.